Literatur
- 1
Rheumatic fever and rheumatic heart disease.
World Health Organ Tech Rep Ser.
2004;
923
1-122
- 2
Klein A L, Burstow D J, Tajik A J. et al .
Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive
color flow examination of 118 volunteers.
J Am Soc Echocardiogr.
1990;
3
54-63
- 3
Soler-Soler J, Galve E.
Worldwide perspective of valve disease.
Heart.
2000;
83
721-725
- 4
Singh J P, Evans J C, Levy D. et al .
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation
(the Framingham Heart Study).
Am J Cardiol.
1999;
83
897-902
- 5
Iung B, Vahanian A.
Valvular heart diseases in elderly people.
Lancet.
2006;
368
969-971
- 6
Nkomo V T, Gardin J M, Skelton T N, Gottdiener J S, Scott C G, Enriquez-Sarano M.
Burden of valvular heart diseases: a population-based study.
Lancet.
2006;
368
1005-1011
- 7
Iung B, Baron G, Butchart E G. et al .
A prospective survey of patients with valvular heart disease in Europe: The
Euro Heart Survey on Valvular Heart Disease.
Eur Heart J.
2003;
24
1231-1243
- 8
Grewal K S, Malkowski M J, Piracha A R. et al .
Effect of general anesthesia on the severity of mitral regurgitation by transesophageal
echocardiography.
Am J Cardiol.
2000;
85
199-203
- 9
Bursi F, Enriquez-Sarano M, Nkomo V T. et al .
Heart failure and death after myocardial infarction in the community: the emerging
role of mitral regurgitation.
Circulation.
2005;
111
295-301
- 10
Spain M G, Smith M D, Grayburn P A, Harlamert E A, DeMaria A N.
Quantitative assessment of mitral regurgitation by Doppler color flow imaging:
angiographic and hemodynamic correlations.
J Am Coll Cardiol.
1989;
13
585-590
- 11
Lancellotti P, Troisfontaines P, Toussaint A C, Pierard L A.
Prognostic importance of exercise-induced changes in mitral regurgitation in
patients with chronic ischemic left ventricular dysfunction.
Circulation.
2003;
108
1713-1717
- 12
St John Sutton M G, Plappert T, Abraham W T. et al .
Effect of cardiac resynchronization therapy on left ventricular size and function
in chronic heart failure.
Circulation.
2003;
107
1985-1990
- 13
Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade L E, Gorcsan III J.
A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization
therapy: insights from mechanical activation strain mapping.
J Am Coll Cardiol.
2004;
44
1619-1625
- 14
Nof E, Glikson M, Bar Lev D, Gurevitz O, Luria D, Eldar M, Schwammenthal E.
Mechanism of diastolic mitral regurgitation in candidates for cardiac resynchronization
therapy.
Am J Cardiol.
2006;
97
1611-1614
- 15
Host U, Kelbaek H, Hildebrandt P, Skagen K, Aldershvile J.
Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse.
Am J Cardiol.
1997;
80
655-658
- 16
Tischler M D, Rowan M, LeWinter M M.
Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic
chronic, severe mitral regurgitation secondary to mitral valve prolapse.
Am J Cardiol.
1998;
82
242-245
- 17
Rosen S E, Borer J S, Hochreiter C. et al .
Natural history of the asymptomatic/minimally symptomatic patient with severe
mitral regurgitation secondary to mitral valve prolapse and normal right and
left ventricular performance.
Am J Cardiol.
1994;
74
374-380
- 18
Otto C M.
Timing of surgery in mitral regurgitation.
Heart.
2003;
89
100-105
- 19
Enriquez Sarano M, Avierinos J F, Messika Zeitoun D. et al .
Quantitative determinants of the outcome of asymptomatic mitral regurgitation.
N Engl J Med.
2005;
352
875-883
- 20
Bonow R O, Carabello B, de Leon Jr A C, Edmunds Jr L H. et al .
Guidelines for the management of patients with valvular heart disease: executive
summary. A report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Committee on Management of Patients with
Valvular Heart Disease).
Circulation.
1998;
98
1949-1984
- 21
Levine R A, Schwammenthal E.
Ischemic mitral regurgitation on the threshold of a solution: from paradoxes
to unifying concepts.
Circulation.
2005;
112
745-758
- 22
Gohlke-Barwolf C, Jander N, Gohlke H, Neumann F-J.
Neue Aspekte zum Management asymptomatischer Patienten mit Mitralinsuffizienz.
Herz.
2006;
31
38-46
- 23
Ruel M, Kapila V, Price J, Kulik A, Burwash I G, Mesana T G.
Natural history and predictors of outcome in patients with concomitant functional
mitral regurgitation at the time of aortic valve replacement.
Circulation.
2006;
114
I541-I546
- 24
Barreiro C J, Patel N D, Fitton T P. et al .
Aortic valve replacement and concomitant mitral valve regurgitation in the elderly:
impact on survival and functional outcome.
Circulation.
2005;
112
I443-I447
- 25
Tubler T, Reichenspurner H, Schofer J.
Mitralklappenrekonstruktion ohne Herz-Lungen-Maschine: Grenzbereich zwischen
Kardiochirurgie und interventioneller Kardiologie. [Mitral valve reconstruction
without cardiopulmonary bypass. Border zone between cardiac surgery and interventional
cardiology].
Herz.
2006;
31
406-412
- 26
Jamieson W E, Cartier P C, Allard M. et al .
Surgical management of valvular heart disease 2004.
Can J Cardiol.
2004;
20
7E-120E
- 27
Ladefoged C, Rohr N.
Amyloid deposits in aortic and mitral valves. A clinicopathological investigation
of material from 100 consecutive heart valve operations.
Virchows Arch A Pathol Anat Histopathol.
1984;
404
301-312
- 28
Valocik G, Kamp O, Mannaerts H F, Visser C A.
New quantitative three-dimensional echocardiographic indices of mitral valve
stenosis: New 3D indices of mitral stenosis.
Int J Cardiovasc Imaging.
2007 (epub ahead of print);
- 29
Hecker S L, Zabalgoitia M, Ashline P, Oneschuk L, O'Rourke R A, Herrera C J.
Comparison of exercise and dobutamine stress echocardiography in assessing mitral
stenosis.
Am J Cardiol.
1997;
80
1374-1377
- 30
Horstkotte D, Niehues R, Strauer B E.
Pathomorphological aspects, aetiology and natural history of acquired mitral
valve stenosis.
Eur Heart J.
1991;
12 Suppl B
55-60
- 31
Iung B, Nicoud-Houel A, Fondard O. et al .
Temporal trends in percutaneous mitral commissurotomy over a 15-year period.
Eur Heart J.
2004;
25
701-707
- 32
Vahanian A, Acar C.
Percutaneous valve procedures: what is the future?.
Curr Opin Cardiol.
2005;
20
100-106
- 33
Sivadasanpillai H, Srinivasan A, Sivasubramoniam S, Mahadevan K K, Kumar A, Titus T,
Tharakan J.
Long-term outcome of patients undergoing balloon mitral valvotomy in pregnancy.
Am J Cardiol.
2005;
95
1504-1506
- 34
Chen C R, Cheng T O.
Percutaneous balloon mitral valvuloplasty by the Inoue technique: a multicenter
study of 4832 patients in China.
Am Heart J.
1995;
129
1197-1203
- 35
Grunkemeier G L, Starr A, Rahimtoola S H.
Prosthetic heart valve performance: long-term follow-up.
Curr Probl Cardiol.
1992;
17
329-406
- 36
Appelbaum A, Kouchoukos N T, Blackstone E H, Kirklin J W.
Early risks of open heart surgery for mitral valve disease.
Am J Cardiol.
1976;
37
201-209
- 37
Bonchek L I, Anderson R P, Starr A.
Mitral valve replacement with cloth-covered composite-seat prostheses. The case
for early operation.
J Thorac Cardiovasc Surg.
1974;
67
93-109
- 38
Junod F L, Harlan B J, Payne J. et al .
Preoperative risk assessment in cardiac surgery: comparison of predicted and
observed results.
Ann Thorac Surg.
1987;
43
59-64
- 39
Arom K V, Nicoloff D M, Kersten T E, Northrup W F, Lindsay W G, Emery R W.
Ten years' experience with the St. Jude Medical valve prosthesis.
Ann Thorac Surg.
1989;
47
831-837
- 40
Cohen L H, Koster J K, Mee R B, Collins Jr J J.
Long-term follow-up of the Hancock bioprosthetic heart valve: a 6-year review.
Circulation.
1979;
60 (2 Pt 2)
87-92
- 41
Lytle B W, Cosgrove D M, Gill C C. et al .
Mitral valve replacement combined with myocardial revascularization: early and
late results for 300 patients, 1970 to 1983.
Circulation.
1985;
71
1179-1190
- 42
Starr A, Grunkemeier G, Lambert L, Okies J E, Thomas D.
Mitral valve replacement: a 10-year follow-up of non-cloth-covered vs. cloth-covered
caged-ball prostheses.
Circulation.
1976;
54 (6 Suppl)
III47-III56
- 43 Braunwald E. Essential atlas of heart diseases. Current Medicine 1997: 8-5
Prof. Dr. R. H. Strasser, F.E.S.C.
Technische Universität Dresden
Herzzentrum Dresden, Universitätsklinik
Klinik für Innere Medizin und Kardiologie
Fetscherstr. 76
01307 Dresden
Email: ruth.strasser@mailbox.tu-dresden.de
